Adaptimmune Therapeutics (ADAP) Tops Q3 EPS by 2c

November 10, 2016 6:33 AM EST
Get Alerts ADAP Hot Sheet
Price: $4.51 +0.67%

Today's EPS Names:
PG, CFG, GE, More
Trade ADAP Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Adaptimmune Therapeutics (NASDAQ: ADAP) reported Q3 EPS of ($0.26), $0.02 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $5.32 million.

For earnings history and earnings-related data on Adaptimmune Therapeutics (ADAP) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment